Reviving exhausted immune cells boosts tumor elimination
Peer-Reviewed Publication
Updates every hour. Last Updated: 28-Dec-2025 10:11 ET (28-Dec-2025 15:11 GMT/UTC)
The menstrual taboo persists. This is the main conclusion of a pioneering macro-study in Spain involving more than 4,000 participants and led by the INGENIO Institute, a joint centre of the Spanish National Research Council (CSIC) and the Universitat Politécnica de València (UPV). According to the analysis, 4 out of 10 people perceive menstruation as a topic that is still stigmatised.
One person’s side effect could be another person’s treatment if we expand our perspective on small molecule drug targets, according to a new study published November 5, 2025, in npj Precision Oncology.
“Small molecules can have different targets and effects depending on the disease and cell type, and we can use this knowledge to repurpose more drugs to treat more patients,” said lead author Sanju Sinha, PhD, an assistant professor at Sanford Burnham Prebys.